---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-031264"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2023-07-03T23:59:59+00:00"
generated_at: "2026-06-13T13:22:10.520016+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Renalytix transitions to U.S. domestic issuer status, adopts new disclosure channels

## Summary
- Effective July 1, 2023, Renalytix began filing periodic reports and registration statements on U.S. domestic issuer forms.
- Previously qualified as a foreign private issuer; now required to file more detailed and timely disclosures with the SEC.
- Company will disseminate material information via SEC filings, press releases, public calls, its website, and LinkedIn.
- Investors encouraged to monitor listed channels for potentially material information.

## SEC filing metadata
- accession: 0000950170-23-031264
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2023-07-03T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017023031264/0000950170-23-031264-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017023031264/rnlx-20230703.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-031264
- JSON: https://secwatch.observer/filing/0000950170-23-031264.json
- Plain text: https://secwatch.observer/filing/0000950170-23-031264.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.